Aspirin
Who holds supplier records for Aspirin? 7 organisations hold a current record for Aspirin: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), India (2), France (1) and Spain (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Aspirin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/aspirin
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Aspirin expires 29 Sept 2032. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Aspirin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- NOVACYL SASFranceCEP Company GMP cert on recordActive DMF 12092 · latest filing Aug 1996
- SHANDONG XINHUA PHARMACEUTICAL CO LTDChinaCEP Company GMP cert on recordActive DMF 10730 · latest filing Jan 1994
- THE ANDHRA SUGARS LTDIndiaCEPActive DMF 16345 · latest filing Dec 2002
- HEBEI JINGYE MEDICAL TECHNOLOGY CORP LTDChinaActive DMF 33010 · latest filing Jul 2018
- JQC (Huayin) Pharmaceutical Co., Ltd.ChinaActive DMF 29823, 38669 · latest filing Aug 2023
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 35315 · latest filing Oct 2020
- BAYER HISPANIA, S.L.SpainCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Aspirin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| BAYER HISPANIA, S.L. Langreo | ES | CEP 2001-292 - Rev 05 Acetylsalicylic acid | Oct 2025 | Inspected Apr 2025 Spain |
| The Andhra Sugars Limited Tanuku | IN | CEP 2000-042 - Rev 05 Acetylsalicylic acid | Apr 2025 | — |
| NOVACYL Ecully | FR | R2-CEP 1993-007 - Rev 06 Acetylsalicylic acid | Aug 2022 | — |
| SHANDONG XINHUA PHARMACEUTICAL CO., LTD. Zibo | CN | R1-CEP 2001-210 - Rev 05 Acetylsalicylic acid | Nov 2016 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (10)
Organisations whose Type II DMFs for Aspirin are no longer active. These show a past filing, not current supply.
Show all 10 historical records
- HEBEI JINGYE CHEMICAL CO LTDInactive DMF 22594 · filed Dec 2008
- INDUSTRIA QUIMICA ANDINA Y CIA SAInactive DMF 15673 · filed Oct 2001
- INDUSTRIES MONFEL S.A. DE C.V.Inactive DMF 15391 · filed Apr 2001
- Germany · Inactive DMF 15149 · filed Nov 2000
- NORISTAN LTDInactive DMF 11128 · filed Oct 1994
- PHARMACEUTICAL WORKS POLPHARMA SAInactive DMF 10386 · filed Jul 1993
- CHEMISCHE FABRIK WEYL GMBHInactive DMF 7313 · filed Feb 1988
- ILKIM ASInactive DMF 6019 · filed Sept 1985
- United States · Inactive DMF 5901 · filed Jul 1985
- BAYER CORPInactive DMF 4805 · filed Jan 1983
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (2 listed products contain Aspirin). The latest listed patent expires 29 Sept 2032. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Aspirin is a pharmaceutical drug used to reduce pain, fever, or inflammation. It is classified as a non-steroidal anti-inflammatory drug (NSAID) and has antiplatelet properties that are useful for preventing and treating cardiac events.
Chemical identity
- IUPAC name
- 2-acetyloxybenzoic acid
- Canonical SMILES
- CC(=O)OC1=CC=CC=C1C(=O)O
- InChIKey
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N
- Synonyms
- Acetylsalicylic Acid; ASA, aspirin, ACETYLSALICYLIC ACID, 2-Acetoxybenzoic acid, 2-(Acetyloxy)benzoic acid, Acylpyrin, O-Acetylsalicylic acid, o-Acetoxybenzoic acid, Acenterine, Acetophen, Ecotrin, Salicylic acid acetate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor
- Mechanism of action
- Cyclooxygenase Inhibitors
- Physiologic effect
- Decreased Platelet Aggregation; Decreased Prostaglandin Production
- Chemical structure
- Non-Steroidal
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Aspirin?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Aspirin: NOVACYL SAS (France), SHANDONG XINHUA PHARMACEUTICAL CO LTD (China), THE ANDHRA SUGARS LTD (India), HEBEI JINGYE MEDICAL TECHNOLOGY CORP LTD (China), JQC (Huayin) Pharmaceutical Co., Ltd. (China), Zydus Lifesciences Limited (India) and BAYER HISPANIA, S.L. (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Aspirin Drug Master Files are active?
NOVACYL SAS (DMF 12092), SHANDONG XINHUA PHARMACEUTICAL CO LTD (DMF 10730), THE ANDHRA SUGARS LTD (DMF 16345), HEBEI JINGYE MEDICAL TECHNOLOGY CORP LTD (DMF 33010), JQC (Huayin) Pharmaceutical Co., Ltd. (DMF 29823, 38669) and Zydus Lifesciences Limited (DMF 35315). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Aspirin records mean?
10 organisations have only inactive Type II DMFs for Aspirin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Aspirin have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Aspirin on the EDQM register, including BAYER HISPANIA, S.L. Langreo (ES), The Andhra Sugars Limited Tanuku (IN), NOVACYL Ecully (FR) and SHANDONG XINHUA PHARMACEUTICAL CO., LTD. Zibo (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Aspirin?
Yes. The latest patent listed for an approved US product containing Aspirin expires 29 Sept 2032, across 2 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Aspirin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Aspirin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.